Partnerre Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Partnerre Ltd (PREJ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Partnerre Ltd vs Its Competitors
- TTM: Trailing 12-month revenue of 9,123M vs 1,154,887M combined for tracked competitors (0.8% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs decelerating (-12.0%) for its tracked peer group.
- Growth: Partnerre Ltd generated 59.3% revenue growth year over year in Q4 2023, vs 15.5% for its tracked competitors combined.
- Profitability: Its 25.4% net margin compares with 20.1% for the peer group.
- Peer revenue share: Partnerre Ltd accounted for 3.5% of combined revenue among its tracked peer group, up from 2.5% a year earlier.
- Peer differentiation: Revenue per employee of $9.12M compares with $1.30M for the peer group (7.0x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PREJ Sales vs. its Competitors, Q4 2023
Partnerre Ltd reported revenue growth of 59.30 % year on year in Q4 2023, above its competitors' combined revenue growth of 15.46 %.
With a net margin of 25.41 %, Partnerre Ltd achieved higher profitability than its competitors (20.08 %).
Partnerre Ltd generated 3.47 % of the combined sales of its peer group, up from 2.54 % a year earlier.
Partnerre Ltd vs. its Competitors, Q4 2023
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Partnerre Ltd and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Partnerre Ltd | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Partnerre Ltd's competitor groups requires a Commercial License.
For context: the Accident & Health Insurance industry grew revenue 7.3% year over year, combined, vs 59.3% for Partnerre Ltd. Partnerre Ltd's share of combined industry revenue moved from 1.62% to 2.40%, a gain of 0.78 percentage points.
Partnerre Ltd's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Partnerre Ltd | Yes | Yes | Yes | No |
| Competitors combined (55) | ||||
| High-Confidence Competitors (6) | ||||
| Similar Growth & Profitability (8) | 87.50 % (7 of 8) | 100.00 % (8 of 8) | 87.50 % (7 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
PREJ Stock Performance relative to its Competitors
PREJ Stock Performance relative to High-Confidence Competitors
PREJ Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | United Fire Group Inc | 282.9% | Outperformed |
| 2 | Planet Labs Pbc | 282.9% | Outperformed |
| 3 | Siriuspoint Ltd | 282.9% | Outperformed |
| 4 | Principal Financial Group inc | 282.9% | Outperformed |
| 5 | Cno Financial Group Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Partnerre Ltd's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Partnerre Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Partnerre Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Partnerre Ltd | - | 9,122.84 |
| Marsh and Mclennan Companies Inc | 81,472.46 | 27,968.00 |
| The Cigna Group | 71,752.79 | 282,382.00 |
| Metlife Inc | 61,985.96 | 79,403.00 |
| Aon Plc | 58,202.19 | 17,603.00 |
| Aflac Incorporated | 57,408.38 | 18,069.00 |
| SUBTOTAL | 753,373.79 | 1,180,375.48 |
Sign in to see all competitors of Partnerre Ltd .
Sources: Partnerre Ltd's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Partnerre Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Partnerre Ltd's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Arch Capital Group Ltd | Named by the company | 85% |
| Munich Re | Named by the company | 85% |
| Transatlantic | Named by the company | 85% |
| GenRe | Named by the company | 85% |
| SCOR SE | Named by the company | 85% |
| RenRe | Named by the company | 85% |
| Hannover Re | Named by the company | 85% |
| Swiss Re | Named by the company | 85% |
| Everest Re | Named by the company | 85% |
| RGA | Named by the company | 85% |
| Renaissancere Holdings Ltd | Named by the company | 85% |
| Oxbridge Re Holdings Limited | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Partnerre Ltd's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Partnerre Ltd's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Partnerre Ltd | Property and Casualty 43.25 % |
| Marsh and Mclennan Companies Inc | Marsh Insurance Group 55.79 % |
| The Cigna Group | Evernorth 85.32 % |
| Metlife Inc | Group Benefits 36.13 % |
| Aon Plc | Risk Capital 70.80 % |
| Aflac Incorporated | Aflac Japan 52.49 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Partnerre Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Partnerre Ltd | - | 9,122,836 | 2,318,119 |
| Marsh and Mclennan Companies Inc | 81,472 | 294,400 | 42,821 |
| The Cigna Group | 71,753 | 4,171,078 | 103,146 |
| Metlife Inc | 61,986 | 1,726,152 | 79,543 |
| Aon Plc | 58,202 | 293,383 | 65,650 |
| Aflac Incorporated | 57,408 | 1,420,966 | 382,353 |
| PEERS TOTAL | 753,374 | 1,296,556 | 173,195 |
Partnerre Ltd's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Aon Plc | Europe, Middle East, and Africa, Other Than United Kingdom and Ireland 16.91 % |
| Planet Labs Pbc | North America 42.93 % |
| Blacksky Technology Inc | Non-US 52.87 % |
| Citizens Inc | All Countries 66.88 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Partnerre Ltd's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Accident & Health Insurance industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (16 companies). See the full Accident & Health Insurance industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 28.17 % | 30.59 % (avg) | -2.4 pp |
| Operating Margin | 28.16 % | industry median | +23.2 pp |
| EBITDA Margin | 22.70 % | 6.78 % (avg) | +15.9 pp |
| Capital Intensity (Capex / Revenue) | 0.00 % | 0.39 % (avg) | -0.4 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Partnerre Ltd's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -17.04 % | 300.55 % | -1.49 % | 40.88 % | - | 0.46 % | -22.60 % | 59.30 % |
| Operating Margin | 21.39 % | 12.14 % | 2.23 % | 18.87 % | 9.02 % | 15.13 % | -9.95 % | 28.16 % |
| Return on Invested Capital | 1.56 % | 3.58 % | 0.72 % | 7.66 % | 3.39 % | 5.07 % | -1.69 % | 6.59 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Partnerre Ltd's Strategic Group Map
Every company in Partnerre Ltd's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Partnerre Ltd is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Partnerre Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.00 % vs industry average 0.39 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Partnerre Ltd's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Partnerre Ltd's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Partnerre Ltd's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Partnerre Ltd falls in the Low attractiveness / High strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Partnerre Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 23.2 points above the industry median.
- Return on equity 9.3 points above the industry aggregate.
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
No rule matched.
Opportunities
- Industry revenue growing at a healthy 12.3% median pace.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-12.0% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Partnerre Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Partnerre Ltd | 0.01 | 0.27 | 0.22 |
| Marsh and Mclennan Companies Inc | 0.68 | 1.13 | 1.33 |
| The Cigna Group | 0.12 | 0.82 | 0.76 |
| Metlife Inc | 0.08 | 0.29 | 0.70 |
| Aon Plc | 0.05 | 1.06 | 1.66 |
| Aflac Incorporated | 0.08 | 2.34 | 0.28 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Partnerre Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Partnerre Ltd | Q4 2023 | +59.3 % | - |
| Marsh and Mclennan Companies Inc | Q2 2026 | +6.1 % | +4.9 % |
| The Cigna Group | Q2 2026 | +6.7 % | +22.4 % |
| Metlife Inc | Q2 2026 | +10.5 % | +6.0 % |
| Aon Plc | Q2 2026 | +2.2 % | -4.9 % |
| Aflac Incorporated | Q2 2026 | -1.0 % | +37.7 % |
| PEERS TOTAL | +8.1 % | +64.9 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Partnerre Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Partnerre Ltd | Q4 2023 | +1.7 % | - |
| Marsh and Mclennan Companies Inc | Q2 2026 | - | +22.0 % |
| The Cigna Group | Q2 2026 | +6.4 % | - |
| Metlife Inc | Q2 2026 | +1,959.3 % | - |
| Aon Plc | Q2 2026 | - | +14.1 % |
| Aflac Incorporated | Q2 2026 | +5.7 % | - |
Partnerre Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Partnerre Ltd | 7.60% | 7.55% | 27.52% |
| Marsh and Mclennan Companies Inc | 6.90% | 11.32% | 26.71% |
| The Cigna Group | 4.46% | 6.88% | 16.50% |
| Metlife Inc | 0.49% | 0.77% | 12.93% |
| Aon Plc | 7.60% | 9.54% | 42.34% |
| Aflac Incorporated | 4.13% | 9.64% | 16.42% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Partnerre Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Partnerre Ltd | - | - |
| Marsh and Mclennan Companies Inc | 20.71 | 2.91 |
| The Cigna Group | 11.27 | 0.25 |
| Metlife Inc | 18.39 | 0.78 |
| Aon Plc | 15.02 | 3.31 |
| Aflac Incorporated | 12.25 | 3.18 |
| PEERS AVERAGE | 4.74 | 0.64 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.